- Q2 2024 Numinus Wellness Inc Earnings Call TranscriptApr 15, 2024€0.0427 (-32.44%)Earnings
- Q1 2024 Numinus Wellness Inc Earnings Call TranscriptJan 15, 2024Earnings
- Q3 2023 Numinus Wellness Inc Earnings Call TranscriptJul 17, 2023€0.16 (-2.08%)Earnings
- Numinus Wellness Inc at OTC Markets Small Cap Growth Investor Conference (Virtual) TranscriptJul 13, 2023
- Q2 2023 Numinus Wellness Inc Earnings Call TranscriptApr 13, 2023€0.1406 (+0.14%)Earnings
- Numinus Wellness Inc Annual Shareholders Meeting TranscriptFeb 15, 2023
- Q1 2023 Numinus Wellness Inc Earnings Call TranscriptJan 16, 2023€0.1657 (+13.03%)Earnings
- Numinus Wellness Inc at OTC Markets KCSA Mental Health Investor Conference TranscriptDec 15, 2022
- Q4 2022 Numinus Wellness Inc Earnings Call TranscriptNov 29, 2022€0.1677 (-2.90%)Earnings
- Q3 2022 Numinus Wellness Inc Earnings Call TranscriptJul 14, 2022€0.1758 (-2.50%)Earnings
- Q2 2022 Numinus Wellness Inc Earnings Call TranscriptApr 14, 2022€0.3738 (-0.24%)Earnings
- Q1 2022 Numinus Wellness Inc Earnings Call TranscriptJan 20, 2022€0.4704 (-3.96%)Earnings
- Q4 2021 Numinus Wellness Inc Earnings Call TranscriptDec 09, 2021€0.3526 (-3.71%)Earnings
Q1 2023 Numinus Wellness Inc Earnings Call Transcript
Good afternoon, and welcome to Numinus Wellness Inc.'s fiscal first-quarter 2023 results conference call. A question-and-answer session for analysts and institutional investors will follow the formal remarks. As a reminder, this call is being recorded. I would now like to turn the conference call over to your host, Jamie Kokoska, Vice President, Investor Relations. Please proceed.
Thank you, [Emma]. Good afternoon, everyone, and thank you for joining us for our fiscal first-quarter 2023 results conference call. Discussing Numinus's performance today are Payton Nyquvest, Founder and CEO; and John Fong, Chief Financial Officer. Joining them for analyst questions at the end of our formal remarks are Reid Robison, Chief Clinical Officer; and Paul Thielking, Chief Science Officer.
The following discussion may include forward-looking statements that are based on current expectations and are subject to a number of risks and uncertainties. The risks and uncertainties that could cause
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)